Inogen Inc·4

Jun 5, 4:44 PM ET

Glezer Stanislav 4

4 · Inogen Inc · Filed Jun 5, 2023

Insider Transaction Report

Form 4
Period: 2023-06-01
Glezer Stanislav
EVP, Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2023-06-01$10.37/sh393$4,0757,216 total
  • Exercise/Conversion

    Common Stock

    2023-06-01+7687,609 total
  • Exercise/Conversion

    Restricted Stock Unit

    2023-06-017686,918 total
    Common Stock (768 underlying)
Footnotes (3)
  • [F1]The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2023.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
  • [F3]Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION